U.S. Markets close in 2 hrs 23 mins
  • S&P 500

    4,123.48
    -5.32 (-0.13%)
     
  • Dow 30

    33,695.68
    -104.92 (-0.31%)
     
  • Nasdaq

    13,845.91
    -54.28 (-0.39%)
     
  • Russell 2000

    2,234.83
    -8.65 (-0.39%)
     
  • Crude Oil

    59.66
    +0.34 (+0.57%)
     
  • Gold

    1,732.60
    -12.20 (-0.70%)
     
  • Silver

    24.87
    -0.45 (-1.80%)
     
  • EUR/USD

    1.1919
    +0.0014 (+0.1192%)
     
  • 10-Yr Bond

    1.6750
    +0.0090 (+0.54%)
     
  • Vix

    17.41
    +0.72 (+4.31%)
     
  • GBP/USD

    1.3743
    +0.0037 (+0.2707%)
     
  • USD/JPY

    109.3730
    -0.2770 (-0.2526%)
     
  • BTC-USD

    59,930.74
    +223.28 (+0.37%)
     
  • CMC Crypto 200

    1,281.43
    -13.15 (-1.02%)
     
  • FTSE 100

    6,889.12
    -26.63 (-0.39%)
     
  • Nikkei 225

    29,538.73
    -229.33 (-0.77%)
     

Patterson’s 3Q Results Beat The Street Consensus; Shares Dip 7%

  • Oops!
    Something went wrong.
    Please try again later.
support@smarteranalyst.com (Ben Mahaney)
·2 min read
  • Oops!
    Something went wrong.
    Please try again later.

Patterson Cos., a dental and animal health products seller reported better-than-expected fiscal 3Q earnings, driven by higher net sales and improved margins. However, shares closed 6.7% lower on March 3, as the company did not provide 4Q guidance citing the continued uncertainty related to the COVID-19 pandemic.

Patterson (PDCO) reported 3Q adjusted earnings of $0.58 per share that surpassed analysts’ expectations of $0.51 and jumped 23.4% year-over-year. Adjusted net sales of $1.55 billion beat the Street’s estimates of $1.5 billion and increased 6.9% from the year-ago period.

The company’s dental segment reported a 3.6% year-over-year rise in internal sales in the quarter, driven by growth in consumables. Internal sales growth in the animal health segment was 10%. The adjusted operating margin was 4.6%, up 30 basis points.

Patterson CEO Mark Walchirk commented, “Looking ahead, we remain confident about our strengthened position in each of our end markets and in Patterson’s long-term value creation potential.” (See Patterson stock analysis on TipRanks)

Following the fiscal 3Q results, Piper Sandler analyst Jason Bednar increased the stock’s price target to $34 (13% upside potential) from $33 citing “another quarter of solid execution,” which he “identifies as a sixth consecutive quarter of upside compared to consensus revenue and EPS estimates.”

However, Bednar reiterated a Hold rating amid “lingering uncertainty.”

The rest of the Street is sidelined on the stock with a Hold consensus rating based on 1 Buy, 3 Holds, and 1 Sell. The average analyst price target of $33.80 implies about 12% upside potential to current levels. Shares have jumped about 26% over the past year.

According to TipRanks’ Smart Score system, Patterson gets a 5 out of 10, which indicates that the stock is likely to perform in line with market averages.

Related News:
Nektar Posts Better-Than-Feared Quarterly Loss, Misses On Revenues
Domino’s 4Q Results Miss Analysts’ Expectations; Shares Tank 7%
Sage Posts Surprise Quarterly Profit As Sales Surge; Shares Pop 6%

More recent articles from Smarter Analyst: